A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

The commercialisation of junk food, increase in inactive lifestyles with prolonged sitting, and high stress environments, ...

A new report noted that body mass index does not provide a nuanced enough assessment of health as it relates to weight ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...

A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...